EVOGENE ($EVGN) posted quarterly earnings results for Q1 2026 on Wednesday, May 20th. The company reported earnings of -$0.60 per share, missing estimates of -$0.28 by $0.32. The company also reported revenue of $330,000, missing estimates of $357,000 by $-27,000.
You can see Quiver Quantitative's $EVGN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EVOGENE Hedge Fund Activity
We have seen 3 institutional investors add shares of EVOGENE stock to their portfolio, and 10 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC added 456,587 shares (+inf%) to their portfolio in Q1 2026, for an estimated $351,571
- CITADEL ADVISORS LLC removed 88,764 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $68,348
- JANE STREET GROUP, LLC removed 19,442 shares (-51.2%) from their portfolio in Q1 2026, for an estimated $14,970
- TWO SIGMA SECURITIES, LLC added 12,465 shares (+inf%) to their portfolio in Q1 2026, for an estimated $9,598
- XTX TOPCO LTD removed 9,963 shares (-43.9%) from their portfolio in Q1 2026, for an estimated $7,671
- MORGAN STANLEY removed 5,200 shares (-57.5%) from their portfolio in Q1 2026, for an estimated $4,004
- UBS GROUP AG added 5,155 shares (+430.7%) to their portfolio in Q1 2026, for an estimated $3,969
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
